Finally, our results reveal that targeting host LD biogenesis by inhibiting SKI-1/S1P endoproteolytic activity may have farreaching applications in the therapeutic treatment of other important human Flaviviridae viruses such as dengue virus, whose replication and pathogenesis also depend on the interaction with lipid droplets [7] . 